Dosage & Administration Drug label Prior authorization Financial assistance

Zubsolv

(buprenorphine / naloxone)

buprenorphine 0.7 MG / naloxone 0.18 MG Sublingual Tablet [Zubsolv]buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet [Zubsolv]

View 4 more

NO BLACK BOX WARNING

Dosage & administration

* Prescription use of this product is limited under the Drug Addiction Treatment Act.

* Following induction, ZUBSOLV is administered sublingually as a single daily dose.

* Strongly consider prescribing naloxone at the time ZUBSOLV is initiated or renewed because patients being treated for opioid use disorder have the potential for relapse, putting them at risk for opioid overdose.

* To avoid precipitating withdrawal, induction with ZUBSOLV should be undertaken when objective and clear signs of withdrawal are evident and ZUBSOLV should be administered in divided doses when used as initial treatment.

* For patients dependent on short-acting opioid products who are in opioid withdrawal; on Day 1, administer up to 5.7 mg/1.4 mg of ZUBSOLV (in divided doses). On Day 2, administer up to a total dose of 11.4 mg/2.9 mg of ZUBSOLV as a single dose.

* For patients dependent on methadone or long-acting opioid products, induction onto sublingual buprenorphine monotherapy is recommended on Days 1 and 2 of treatment.

* For maintenance treatment, the target dosage of ZUBSOLV is 11.4 mg/2.9 mg as a single daily dose.

* Administer ZUBSOLV as directed in the Full Prescribing Information.

* When discontinuing treatment, gradually taper to avoid signs and symptoms of withdrawal.

drug label

Zubsolv prescribing information

Report Adverse Event

prior authorization

Zubsolv prior authorization resources

PDFComplete Letter of Medical Necessity

Learn More

financial assistance

Zubsolv financial assistance options

Co-pay savings program

commercial only

OTHEREnroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

patient education

Zubsolv patient education

Getting started on Zubsolv

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link